<DOC>
	<DOCNO>NCT01415167</DOCNO>
	<brief_summary>The purpose registry collect information patient receive treatment Proleukin organize way , learn patient care treatment .</brief_summary>
	<brief_title>PROCLAIM Registry Evaluate Treatment Patterns Clinical Response Malignancy</brief_title>
	<detailed_description>The PROCLAIM Registry US-based , multicenter Registry design establish high quality observational database real-world clinical data HD IL-2 use treat patient mRCC , mM malignancy . The Registry , way , suggest change treatment management patient enrol Registry . Therefore , physician continue manage treat patient accord standard care judgment . The PROCLAIM Registry start retrospective pilot data collection de-identified finite number patient case abstract exist medical chart . The feature collect identical plan prospective registry . The result database use formulate hypothesis test use prospective registry database . Patients utilized retrospective analysis exclude prospective portion Registry . In prospective portion Registry , sit enroll patient expect start course HD IL-2 therapy . Once enrolled , patient must receive least one dose HD IL-2 remain Registry . Patients treat follow accord site 's standard care . This Registry way induce change management individual patient . Clinical data feature enter Electronic Data Capture ( EDC ) system , organize registry database . The data contain registry database observational data . The PROCLAIM Registry stipulate patient care , specific visit intervention merely survey standardize parameter regard HD IL-2 associated therapy apply treatment center . The collection standard data time permit evaluation trend patient survival subsequent therapy exposure . The database use answer future query formulate researcher .</detailed_description>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>18 year old Must receive least one course high dose IL2 Proleukin Signed informed consent form Prior high dose IL2 Proleukin therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>